Zou J - Search Results

1

Letter to the editor: HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg-negative patients with chronic HBV infection.

Yang D, Zou J, Wang L, Chen X, Lu F. Yang D, et al. Among authors: zou j. Hepatology. 2022 Oct;76(4):E69-E70. doi: 10.1002/hep.32508. Epub 2022 Jun 24. Hepatology. 2022. PMID: 35383987 No abstract available.

2

Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.

Zhang T, Guan G, Chen T, Jin J, Zhang L, Yao M, Qi X, Zou J, Chen J, Lu F, Chen X. Zhang T, et al. Among authors: zou j. Asia Pac J Clin Oncol. 2018 Oct;14(5):e352-e358. doi: 10.1111/ajco.12982. Epub 2018 May 11. Asia Pac J Clin Oncol. 2018. PMID: 29749051

3

Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.

Liao H, Liu Y, Li X, Wang J, Chen X, Zou J, Li Q, Liu L, Wang J, Huang B, Lu F, Xu D. Liao H, et al. Among authors: zou j. Antivir Ther. 2019;24(2):105-115. doi: 10.3851/IMP3280. Antivir Ther. 2019. PMID: 30511941

4

Correction: Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.

Liao H, Liu Y, Li X, Wang J, Chen X, Zou J, Li Q, Liu L, Wang J, Huang B, Lu F, Xu D. Liao H, et al. Among authors: zou j. Antivir Ther. 2019;24(2):151. doi: 10.3851/IMP3314. Antivir Ther. 2019. PMID: 31050658 No abstract available.

5

Hepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of Irreversible DNA Chain Termination.

Liu Y, Liu H, Hu Z, Ding Y, Pan XB, Zou J, Xi J, Yu G, Huang H, Luo MT, Guo F, Liu S, Sheng Q, Jia J, Zheng YT, Wang J, Chen X, Guo JT, Wei L, Lu F. Liu Y, et al. Among authors: zou j. Hepatology. 2020 Feb;71(2):463-476. doi: 10.1002/hep.30844. Epub 2019 Aug 19. Hepatology. 2020. PMID: 31278760 Free PMC article.

6

HBV Genome and Life Cycle.

Wang J, Huang H, Liu Y, Chen R, Yan Y, Shi S, Xi J, Zou J, Yu G, Feng X, Lu F. Wang J, et al. Among authors: zou j. Adv Exp Med Biol. 2020;1179:17-37. doi: 10.1007/978-981-13-9151-4_2. Adv Exp Med Biol. 2020. PMID: 31741332 Review.

7

Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11.

Shen C, Feng X, Mao T, Yang D, Zou J, Zao X, Deng Q, Chen X, Lu F. Shen C, et al. Among authors: zou j. Emerg Microbes Infect. 2020 Dec;9(1):2455-2464. doi: 10.1080/22221751.2020.1840311. Emerg Microbes Infect. 2020. PMID: 33084547 Free PMC article.

8

NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription.

Zao X, Cheng J, Shen C, Guan G, Feng X, Zou J, Zhang J, Liu T, Zheng H, Zhang T, Wang J, Liu J, Li D, Lu F, You F, Chen X. Zao X, et al. Among authors: zou j. Oncoimmunology. 2021 Jan 11;10(1):1869388. doi: 10.1080/2162402X.2020.1869388. Oncoimmunology. 2021. PMID: 33520407 Free PMC article.

9

A global survey of alternative splicing of HBV transcriptome using long-read sequencing.

Guan G, Zou J, Zhang T, Lu F, Chen X. Guan G, et al. Among authors: zou j. J Hepatol. 2022 Jan;76(1):234-236. doi: 10.1016/j.jhep.2021.07.023. Epub 2021 Jul 29. J Hepatol. 2022. PMID: 34331966 No abstract available.

10

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients.

Yu G, Chen R, Zheng S, Liu Y, Zou J, Gu Z, Jiang B, Gao Q, Dai L, Peng J, Wang J, Lu F. Yu G, et al. Among authors: zou j. Emerg Microbes Infect. 2022 Dec;11(1):775-785. doi: 10.1080/22221751.2022.2045874. Emerg Microbes Infect. 2022. PMID: 35220917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,694 results

Search Page